Exelixis (EXEL)

Add to Watchlists
Create an Alert
3.58 +0.23  +6.87% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD

Exelixis Cash from Financing (TTM):

-11.67M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Exelixis Cash from Financing (TTM) Chart

Export Data
Save Image

Exelixis Historical Cash from Financing (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -11.67M
Sept. 30, 2013 -11.83M
June 30, 2013 404.89M
March 31, 2013 404.20M
Dec. 31, 2012 478.43M
Sept. 30, 2012 478.64M
June 30, 2012 64.36M
March 31, 2012 71.58M
Dec. 31, 2011 187.51M
Sept. 30, 2011 162.12M
June 30, 2011 157.64M
March 31, 2011 313.03M
Dec. 31, 2010 131.26M
Sept. 30, 2010 131.94M
June 30, 2010 131.12M
March 31, 2010 -32.44M
Dec. 31, 2009 -33.99M
Sept. 30, 2009 -12.79M
June 30, 2009 -13.62M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

EXEL Cash from Financing (TTM) Benchmarks

Companies
Regeneron Pharmaceuticals 77.14M
Cyclacel Pharmaceuticals 27.33M
Halozyme Therapeutics 25.06M

EXEL Cash from Financing (TTM) Range, Past 5 Years

Minimum -33.99M Dec 2009
Maximum 478.64M Sep 2012
Average 157.91M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.